Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric G. Carter currently holds 96,210 shares of KING PHARMACEUTICALS INC (KG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric G. Carter has been a net neutral trader of KG stock. They have purchased $0 and sold $0 worth of shares.
Eric G. Carter's most recent insider trade was on Aug 31, 2024, when they sold 96,210 shares at $0.00 per share.
Eric G. Carter serves as Executive at KING PHARMACEUTICALS INC (KG). They have executed 24 insider transactions totaling $0 over their tenure at the company.
Eric G. Carter holds the position of Executive at KING PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Eric G. Carter has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Eric G. Carter was on Nov 29, 2010, when they sold $572.0K worth of KG shares. This transaction involved 40,426 shares at $14.15 per share.
Eric G. Carter currently owns 96,210 shares of KING PHARMACEUTICALS INC (KG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric G. Carter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric G. Carter has 24 Form 4 filings on record as an insider at KING PHARMACEUTICALS INC.
Set alerts for Eric G. Carter and 40,000+ other insiders.